Free fatty acids, complement activation, and polyclonal B-cell stimulation as factors in the immunopathogenesis of African trypanosomiasis
- PMID: 72292
- DOI: 10.1016/s0140-6736(77)90892-3
Free fatty acids, complement activation, and polyclonal B-cell stimulation as factors in the immunopathogenesis of African trypanosomiasis
Abstract
Human and animal forms of African trypanosomiasis are characterised by sustained hypocomplementaemia, gross hypergammaglobulinaemia M, and profound immunosuppression. It is suggested that this hypocomplementaemia is probably due to the action of a trypanosome-derived complement-activating factor and that the elevated IgM levels may be the combined result of this decomplementation, together with a subsequent failure of the normal IgM-to-IgG antibody switch mechanism and polyclonal B-lymphocyte activation by a trypanosome-generated mitogen. The immunosuppression in this disease may be a result of the collective immunosuppressive effects of trypanosome-derived immune-modulating free fatty acids, polyclonally stimulating B-cell mitogen, and complement-activating factors.
Similar articles
-
Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis.Lancet. 1974 Mar 16;1(7855):435-6. doi: 10.1016/s0140-6736(74)92386-1. Lancet. 1974. PMID: 4131434 No abstract available.
-
Immunosuppression in experimental African trypanosomiasis. Polyclonal B-cell activation and mitogenicity of trypanosome-derived saturated fatty acids.Int Arch Allergy Appl Immunol. 1979;59(3):298-307. Int Arch Allergy Appl Immunol. 1979. PMID: 312771
-
Mitogenic activity of an extract of Trypanosoma gambiense.Trans R Soc Trop Med Hyg. 1978;72(4):408-11. doi: 10.1016/0035-9203(78)90137-2. Trans R Soc Trop Med Hyg. 1978. PMID: 309195
-
Hematologic manifestations, diagnosis, and immunopathology of African trypanosomiasis.Semin Hematol. 1982 Apr;19(2):83-92. Semin Hematol. 1982. PMID: 7041266 Review. No abstract available.
-
Immunobiology of African trypanosomiasis.Chem Immunol. 1998;70:186-99. doi: 10.1159/000058706. Chem Immunol. 1998. PMID: 9509676 Review. No abstract available.
Cited by
-
Biologically active products from African Trypanosomes.Microbiol Rev. 1978 Dec;42(4):664-81. doi: 10.1128/mr.42.4.664-681.1978. Microbiol Rev. 1978. PMID: 368556 Free PMC article. Review. No abstract available.
-
Tsetse fly saliva accelerates the onset of Trypanosoma brucei infection in a mouse model associated with a reduced host inflammatory response.Infect Immun. 2006 Nov;74(11):6324-30. doi: 10.1128/IAI.01046-06. Epub 2006 Sep 5. Infect Immun. 2006. PMID: 16954393 Free PMC article.
-
Lysosomal phospholipase A1 in Trypanosoma cruzi: an enzyme with a possible role in the pathogenesis of Chagas' disease.Biochem J. 2001 May 1;355(Pt 3):765-70. doi: 10.1042/bj3550765. Biochem J. 2001. PMID: 11311140 Free PMC article.
-
Control of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-alpha induction.Infect Immun. 2002 Mar;70(3):1342-51. doi: 10.1128/IAI.70.3.1342-1351.2002. Infect Immun. 2002. PMID: 11854219 Free PMC article.
-
Pathogenicity and virulence of African trypanosomes: From laboratory models to clinically relevant hosts.Virulence. 2023 Dec;14(1):2150445. doi: 10.1080/21505594.2022.2150445. Virulence. 2023. PMID: 36419235 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources